{"componentChunkName":"component---node-modules-gatsby-theme-buzzing-src-gatsby-theme-blog-core-templates-post-query-js","path":"/reddit/r/wallstreetbets/comments/l78duc/give_them_nothing_but_take_from_them_everything/","result":{"data":{"site":{"siteMetadata":{"title":"国外股市热门","description":"用中文浏览国外股票社区里的热门讨论","social":[{"name":"Reddit Stocks","url":"https://www.reddit.com/r/stocks","external":true,"prefetch":null},{"name":"Reddit Investing","url":"https://www.reddit.com/r/investing","external":true,"prefetch":null},{"name":"Reddit Bogleheads","url":"https://www.reddit.com/r/Bogleheads/","external":true,"prefetch":null},{"name":"Buzzing","url":"https://www.buzzing.cc/","external":true,"prefetch":null}],"menuLinks":[{"name":"每周精选","url":"/issues","external":null,"prefetch":null}],"localize":[{"title":"Buzzing on Stocks","description":"See popular discussions in foreign stock communities in your native language","locale":"en","social":[{"name":"Reddit","url":"https://www.reddit.com/","external":true,"prefetch":null}],"menuLinks":[{"name":"Weekly Selection","url":"/en/issues","external":null,"prefetch":null}]},{"title":"國外股市熱門","description":"用中文瀏覽國外股票社區裡的熱門討論","locale":"zh-Hant","social":null,"menuLinks":[{"name":"每週精選","url":"/zh-Hant/issues","external":null,"prefetch":null}]},{"title":"米国株式市場人気の話し合います","description":"人気の米国株式市場の話し合いまを日本語で閲覧","locale":"ja","social":null,"menuLinks":[{"name":"每週精選","url":"/ja/issues","external":null,"prefetch":null}]}]}},"blogPost":{"__typename":"SocialMediaPost","id":"RedditPost-l78duc","excerpt":"","body":"","slug":"/reddit/r/wallstreetbets/comments/l78duc/give_them_nothing_but_take_from_them_everything/","title":"Give them nothing, but take from them everything","tags":["wallstreetbets","reddit"],"date":"January 29, 2021","dateISO":"2021-01-29T02:44:18.000Z","datetime":"2021-01-29 02:44","image":null,"imageAlt":"Reddit Image","socialImage":null,"fields":{"basePath":"/"},"thirdPartyId":"l78duc","provider":"Reddit","url":"https://www.reddit.com/r/wallstreetbets/comments/l78duc/give_them_nothing_but_take_from_them_everything/","originalUrl":"https://www.reddit.com/r/wallstreetbets/comments/l78duc/give_them_nothing_but_take_from_them_everything/","imageRemote":"https://preview.redd.it/ijenw1bmy4e61.jpg?width=1080&crop=smart&auto=webp&s=24cecbfed48a3a7f343aec95f2d74f22d8035423","video":null,"channel":"wallstreetbets","channelUrl":"https://www.reddit.com/r/wallstreetbets","author":"Baalk_","authorUrl":"https://www.reddit.com/user/Baalk_","authorImage":null,"authorSlug":"Baalk_","score":107946,"views":null,"sharedCount":null,"likeCount":null,"sharedContent":null,"parent":{"__typename":"RedditJson","localize":[{"title":"不给他们任何东西，但要从他们身上拿走一切","the_new_excerpt":null,"locale":"zh"},{"title":"不給他們任何東西，但要從他們身上拿走一切","the_new_excerpt":null,"locale":"zh-Hant"}]}},"previous":{"id":"TweetPost-1358874874308161536","excerpt":"","slug":"/tweet/1358874874308161536","title":"SPACs have been very lucrative for the sponsor.\n\n\"The average SPAC sponsor return less concessions, forfeiture and vesting over the last two years was 648%.\"\n\nFrom Michael Cembalest at JPM https://t.co/OxCgvYJeKX","date":"February 08, 2021","__typename":"SocialMediaPost","parent":{"__typename":"TweetJson","localize":[{"locale":"zh","full_text":"SPACs对赞助商来说是非常有利可图的。\n\n\"过去两年，SPAC保荐人的平均回报率减去让步、没收和归属，为648%。\"\n\n来自JPM的Michael Cembalest https://t.co/OxCgvYJeKX","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh-Hant","full_text":"SPACs對贊助商來說是非常有利可圖的。\n\n\"過去兩年，SPAC保薦人的平均回報率減去讓步、沒收和歸屬，爲648%。\"\n\n來自JPM的Michael Cembalest https://t.co/OxCgvYJeKX","quoted_status_full_text":null,"retweeted_status_full_text":null}]}},"next":{"id":"RedditPost-lfi4a6","excerpt":"AIM ImmunoTech, Inc. operates as a biopharmaceutical company, which engages in\nthe clinical development of new drug therapies based on natural immune system\nenhancing technologies for the treatment of viral and immune based disorders.\nIts products include Alferon N Injection and Ampligen. The…","slug":"/reddit/r/investing/comments/lfi4a6/why_im_bullish_on_aim_immunotech_inc_aim/","title":"Why I'm Bullish on AIM ImmunoTech Inc. ($AIM)","__typename":"SocialMediaPost","date":"February 09, 2021","parent":{"__typename":"RedditJson","localize":[{"title":"为什么我看好AIM ImmunoTech Inc. ($AIM)","the_new_excerpt":"AIM ImmunoTech, Inc.是一家生物制药公司，其经营范围包括\n基于自然免疫系统的新药物疗法的临床开发。\n公司的产品包括Alferon N注射液和Ampligen。\n其产品包括Alferon N注射液和Ampligen。该...","locale":"zh"},{"title":"爲什麼我看好AIM ImmunoTech Inc. ($AIM)","the_new_excerpt":"AIM ImmunoTech, Inc.是一家生物製藥公司，其經營範圍包括\n基於自然免疫系統的新藥物療法的臨牀開發。\n公司的產品包括Alferon N注射液和Ampligen。\n其產品包括Alferon N注射液和Ampligen。該...","locale":"zh-Hant"}]}}},"pageContext":{"id":"RedditPost-l78duc","previousId":"TweetPost-1358874874308161536","nextId":"RedditPost-lfi4a6","maxWidth":1024,"locale":"zh","hrefLang":"zh-Hans","originalPath":"/reddit/r/wallstreetbets/comments/l78duc/give_them_nothing_but_take_from_them_everything/","dateFormat":"YYYY-MM-DD"}},"staticQueryHashes":["1239077767","2506312863","2744905544","3493603132","3493603132","3513215887","386998304"]}